RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Laurencia okamurai Extract Containing Laurinterol Induces Apoptosis in Melanoma Cells

      한글로보기

      https://www.riss.kr/link?id=A104512175

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Laurinterol is a marine sesquiterpene that has been known to have antimicrobial activity. The purpose of thisstudy is to investigate the effect of Laurencia okamuraiextract containing laurinterol (LOEL) on induction of apoptosis inmelanoma cells (B16F...

      Laurinterol is a marine sesquiterpene that has been known to have antimicrobial activity. The purpose of thisstudy is to investigate the effect of Laurencia okamuraiextract containing laurinterol (LOEL) on induction of apoptosis inmelanoma cells (B16F1). Anticancer activity of LOEL against melanoma cells was shown in a dose-dependent manner by the1-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay. It was for the first time found that LOEL exhibitedan excellent effect on the induction of apoptosis as determined by DNA fragmentation, terminal deoxynucleotidyl transferase-mediated dUTP in situnick-end labeling assay, cell cycle analysis, and measurement of activities of several caspases inmelanoma cells. It was also demonstrated that transcriptional activation of p53, a tumor suppressor gene, and activation ofp21 promoter by LOEL were involved in the induction of apoptosis by reporter gene assay. In particular, western blot analy-sis confirmed that LOEL above 5 .g/mL significantly increased the expression level of phospho-p53, the active form. Theseresults indicate that LOEL can induce apoptosis through a p53-dependent pathway in melanoma cells.

      더보기

      참고문헌 (Reference)

      1 Kim, SG, "p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA" 6 : 871-880, 2002

      2 Levine AJ, "p53, the cellular gatekeeper for growth and division" 88 : 323-331, 1997

      3 Tewari M, "Yama/CPP32 beta, a mammalian homolog for CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase" 81 : 801-809, 1995

      4 Cheng SL, "Toxicogenomics of A375 human malignant melanoma cells treated with arbutin" 14 : 87-105, 2007

      5 Henry H, "Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death" 21 : 748-760, 2002

      6 Hansen MB, "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill" 11 : 203-210, 1989

      7 Simmons TL, "Marine natural products as anticancer drugs" 4 : 333-342, 2005

      8 Yuru M, "Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer" 579 : 1311-1319, 2005

      9 Suzuki M, "Halogenated and nonhalogenated aromatic sesquiterpenes from the red algae Laurencia okamurai Yamada" 52 : 3352-3354, 1979

      10 Lin D, "Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase" 89 : 9210-9214, 1992

      1 Kim, SG, "p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA" 6 : 871-880, 2002

      2 Levine AJ, "p53, the cellular gatekeeper for growth and division" 88 : 323-331, 1997

      3 Tewari M, "Yama/CPP32 beta, a mammalian homolog for CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase" 81 : 801-809, 1995

      4 Cheng SL, "Toxicogenomics of A375 human malignant melanoma cells treated with arbutin" 14 : 87-105, 2007

      5 Henry H, "Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death" 21 : 748-760, 2002

      6 Hansen MB, "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill" 11 : 203-210, 1989

      7 Simmons TL, "Marine natural products as anticancer drugs" 4 : 333-342, 2005

      8 Yuru M, "Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer" 579 : 1311-1319, 2005

      9 Suzuki M, "Halogenated and nonhalogenated aromatic sesquiterpenes from the red algae Laurencia okamurai Yamada" 52 : 3352-3354, 1979

      10 Lin D, "Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase" 89 : 9210-9214, 1992

      11 Virgili G, "EUROCARE Working Group: Incidence of uveal melanoma in Europe" 114 : 2309-2315, 2007

      12 Lin MT, "Differential expression of tissue- specific promoters by gene gun" 14 : 34-39, 2001

      13 Sakahira H, "Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis" 39 : 96-99, 1998

      14 Li G, "Chemotherapy-induced apoptosis in melanoma cells is p53 dependent" 8 : 17-23, 1998

      15 Ryan KM, "Characterization of structural p53 mutants which show selective defects in apoptosis, but not cell cycle arrest" 18 : 3692-3698, 1998

      16 Wu GS, "Caspase-9 is required for p53-independent apoptosis and chemosensitivity in a human ovarian cancer cell line" 2 : 1-8, 2002

      17 Janicke RU, "Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis" 27 : 9357-9360, 1998

      18 Carter GT, "Brominated indoles from Laurencia brongniartii" 19 : 4479-4482, 1978

      19 Manson MM, "Blocking and suppressing mechanism of chemoprevention by dietary constituents" 113 : 499-505, 2000

      20 Velculescu VE, "Biological and clinical importance of the p53 tumor suppressor gene" 42 : 858-868, 1996

      21 Basma H, "BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53" 12 : 999-1011, 2005

      22 Yu HS, "Arsenic carcinogenesis in the skin" 13 : 657-666, 2006

      23 Lin HH, "Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification" 14 : 681-694, 2007

      24 Guchelaar HJ, "Apoptosis: molecular mechanisms and implications for cancer chemotherapy" 19 : 119-125, 1997

      25 Sims JJ, "Antimicrobial agents from marine algae" 7 : 320-321, 1975

      26 Vairappan CS, "Antibacterial halogenated metabolites from the Malaysian Laurencia species" 58 : 291-297, 2001

      27 Cirielli C, "Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo" 63 : 673-679, 1995

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2014-06-24 학회명변경 한글명 : 한국식품영양과학회지 -> 한국식품영양과학회
      영문명 : Journal of the Korean Society of Food Science and Nutrition -> The Korean Society of Food Science and Nutrition
      KCI등재
      2014-04-02 학회명변경 한글명 : 한국식품영양과학회 -> 한국식품영양과학회지
      영문명 : 미등록 -> Journal of the Korean Society of Food Science and Nutrition
      KCI등재
      2013-10-01 평가 SCOPUS 등재 (등재유지) KCI등재
      2010-01-01 평가 SCI 등재 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-20 학술지등록 한글명 : Journal of Medicinal Food
      외국어명 : Journal of Medicinal Food
      KCI등재후보
      2005-01-20 학술지등록 한글명 : Journal of Medicinal Food
      외국어명 : Journal of Medicinal Food
      KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.88 0.33 1.35
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.09 0.84 0.536 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼